75 related articles for article (PubMed ID: 8645034)
21. MR staging in carcinoma of the endometrium and carcinoma of the cervix.
Pakkal MV; Rudralingam V; McCluggage WG; Kelly BE
Ulster Med J; 2004 May; 73(1):20-4. PubMed ID: 15244121
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
23. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.
Juretzka MM; Jensen KC; Longacre TA; Teng NN; Husain A
Gynecol Oncol; 2004 Apr; 93(1):107-11. PubMed ID: 15047221
[TBL] [Abstract][Full Text] [Related]
24. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
[TBL] [Abstract][Full Text] [Related]
25. [Lymphatic mapping and parametrial lymph nodes identification in patients with early stage cervical cancer].
Li B; Wu LY; Li XG; Zhang X; Zhang WH; Gao JZ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):608-11. PubMed ID: 17181971
[TBL] [Abstract][Full Text] [Related]
26. Extraperitoneal laparoscopic para-aortic lymphadenectomy as a diagnostic procedure for lymph node recurrence of gynaecological cancers.
Sanjuán A; Illa M; Torné A; Román SM; Jurado M; Lejarcegui JA; Pahisa J
Acta Obstet Gynecol Scand; 2007; 86(4):491-5. PubMed ID: 17486474
[TBL] [Abstract][Full Text] [Related]
27. Is systematic scalene node biopsy in pretreatment evaluation of locally advanced cervical carcinoma necessary? Systematic dissection and histopathology of left scalene node biopsies in patients with locally advanced cervical carcinoma.
Samouëlian V; Baranzelli MC; Narducci F; Taïeb S; Cabaret V; Querleu D; Leblanc E
Gynecol Oncol; 2006 Dec; 103(3):1091-4. PubMed ID: 16890275
[TBL] [Abstract][Full Text] [Related]
28. Status of sentinel lymph nodes in cervical cancer.
Levenback CF
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S18-9. PubMed ID: 17761270
[No Abstract] [Full Text] [Related]
29. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
[TBL] [Abstract][Full Text] [Related]
30. Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia.
Leo C; Richter C; Horn LC; Schütz A; Pilch H; Höckel M
Gynecol Oncol; 2005 May; 97(2):602-6. PubMed ID: 15863166
[TBL] [Abstract][Full Text] [Related]
31. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
32. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
33. Endometrial cancer: can nodal status be predicted with curettage?
Mariani A; Sebo TJ; Katzmann JA; Roche PC; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2005 Mar; 96(3):594-600. PubMed ID: 15721399
[TBL] [Abstract][Full Text] [Related]
34. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging.
Nakai G; Matsuki M; Inada Y; Tatsugami F; Tanikake M; Narabayashi I; Yamada T
J Comput Assist Tomogr; 2008; 32(5):764-8. PubMed ID: 18830107
[TBL] [Abstract][Full Text] [Related]
35. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
36. Effects of thymidine phosphorylase levels in cancer, background mucosa, and regional lymph nodes on survival of advanced gastric cancer patients receiving postoperative fluoropyrimidine therapy.
Kosaka T; Usami K; Ueshige N; Sugaya J; Nakano Y; Takashima S
Oncol Rep; 2004 Dec; 12(6):1279-86. PubMed ID: 15547751
[TBL] [Abstract][Full Text] [Related]
37. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
38. Predictors of lymphatic failure in endometrial cancer.
Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
Gynecol Oncol; 2002 Mar; 84(3):437-42. PubMed ID: 11855884
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical localization of thymidine phosphorylase in primary lung cancer].
Kawamoto M; Fukuda Y; Fukushima M; Kamoi S; Koizumi K; Yamanaka N
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1217-9. PubMed ID: 8751815
[No Abstract] [Full Text] [Related]
40. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
